Neuromodulation in Refractory Bitemporal Lobe Epilepsy in Adults: A Systematic Review and Meta-Analysis
Stereotactic and Functional Neurosurgery · 2025
DOI: 10.1159/000549636 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Stereotactic and Functional Neurosurgery, 2025. Verfasst von Benjamin H Petersen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Oklahoma, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Vagus Nerve Stimulation, Drug Resistant Epilepsy, Epilepsy, Temporal Lobe. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Introduction
Bilateral temporal lobe epilepsy represents a subset of patients with medically intractable epilepsy that is particularly difficult to treat. This systematic review and meta-analysis aimed to evaluate the safety and efficacy of three neuromodulation techniques – vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS) – in refractory bilateral temporal lobe epilepsy (BTLE).
Methods
In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a thorough electronic literature search using Ovid MEDLINE, Ovid Embase, and PubMed databases. Data from the selected studies were extracted, analyzed, and a quality assessment was performed. Meta-analysis was performed comparing mean seizure reduction rates in VNS, RNS, and DBS.
Results
Twenty studies (4 VNS, 7 RNS, 9 DBS) involving 142 BTLE patients were included in the systematic review. Meta-analysis of 12 studies (2 VNS, 5 RNS, 5 DBS) revealed comparable efficacy between VNS (61.69%), RNS (67.51%), and DBS (66.68%), with no statistically significant difference (p = 0.932) between the modalities. All three techniques demonstrated efficacy in seizure reduction. Additionally, complication rates did not significantly differ between VNS, RNS, and DBS.
Conclusion
This study provides a comprehensive assessment of existing data regarding the use of neuromodulation in refractory BTLE. VNS, RNS, and DBS demonstrated comparable efficacy, supporting their consideration in treatment planning. Clinical decision-making should weigh factors such as surgical candidacy, patient preferences, comorbidities, and side effect profiles. Further research, including standardized reporting and head-to-head trials, is vital for optimizing treatment protocols and expanding our understanding of neuromodulation's impact on seizure reduction, quality of life, and cognitive outcomes in patients with BTLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University of Oklahoma, Oklahoma City, Oklahoma, USA.
- Department of Neurosurgery, University of Oklahoma, Oklahoma City, Oklahoma, USA, andrew-conner@ouhsc.edu.
Zitieren
APA
Petersen, B. H., Azaz, Z., Yorke, K., Petersen, S. H., Kharbat, A. F., & Conner, A. K. (2025). Neuromodulation in Refractory Bitemporal Lobe Epilepsy in Adults: A Systematic Review and Meta-Analysis. Stereotactic and Functional Neurosurgery. https://doi.org/10.1159/000549636
Vancouver
Petersen BH, Azaz Z, Yorke K, Petersen SH, Kharbat AF, Conner AK. Neuromodulation in Refractory Bitemporal Lobe Epilepsy in Adults: A Systematic Review and Meta-Analysis. Stereotactic and Functional Neurosurgery. 2025. doi:10.1159/000549636
BibTeX
@article{Petersen2025,
author = {Petersen, Benjamin H and Azaz, Zubair and Yorke, Keith and Petersen, Samuel H and Kharbat, Abdurrahman F and Conner, Andrew K},
title = {Neuromodulation in Refractory Bitemporal Lobe Epilepsy in Adults: A Systematic Review and Meta-Analysis},
journal = {Stereotactic and Functional Neurosurgery},
year = {2025},
doi = {10.1159/000549636}
}
EUVIMED